PLATINUM INVESTMENT MANAGEMENT LTD - UNUM THERAPEUTICS INC ownership

UNUM THERAPEUTICS INC's ticker is UMRX and the CUSIP is 903214104. A total of 41 filers reported holding UNUM THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of UNUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$447,000
-60.9%
170,700
-34.5%
0.01%
-59.3%
Q1 2019$1,144,000
-0.3%
260,5950.0%0.03%
-30.8%
Q4 2018$1,147,000
-36.6%
260,595
+48.3%
0.04%
-23.5%
Q3 2018$1,810,000
-43.9%
175,700
-21.9%
0.05%
-32.9%
Q2 2018$3,229,000
+29.2%
225,0000.0%0.08%
+8.6%
Q1 2018$2,499,000225,0000.07%
Other shareholders
UNUM THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 3,361,535$37,347,00028.23%
Novo Holdings A/S 665,181$31,669,0003.97%
New Leaf Venture Partners, L.L.C. 550,000$6,111,0003.30%
SECTORAL ASSET MANAGEMENT INC 1,081,545$12,016,0001.32%
SABBY MANAGEMENT, LLC 1,106,445$12,292,0000.73%
Monashee Investment Management LLC 175,000$1,944,0000.54%
DC Investments Management, LLC 35,524$395,0000.26%
Athanor Capital, LP 22,300$248,0000.12%
PLATINUM INVESTMENT MANAGEMENT LTD 225,000$2,499,0000.07%
Schonfeld Strategic Advisors LLC 73,000$811,0000.06%
View complete list of UNUM THERAPEUTICS INC shareholders